Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/dAgrCfbwoceqoQlNTPaw

March 27, 2012
Sign upForwardArchiveAdvertise
News for professionals focused on the health of women and newborns

  Women's Health Update 
  • Study: Vitamin E supplements don't affect heart failure risk
    Data from the Women's Health Study showed vitamin E supplements do not raise or lower the overall risk of heart failure in healthy women. Researchers from Massachusetts General Hospital reported in the journal Circulation that larger studies are needed to confirm the study's finding that vitamin E reduced the risk of developing heart failure with a normal ejection fraction, which accounts for about half of cases. Medscape (free registration) (3/20) LinkedInFacebookTwitterEmail this Story
  • Dense breast tissue is tied to higher risk of cancer recurrence
    Breast cancer is more likely to recur in women with a higher percentage of dense breast tissue, according to a study presented at the European Breast Cancer Conference in Vienna. Researchers said breast density should be considered when screening patients and during the development of their treatment plans. Researchers, however, said they did not observe a link between breast density and survival or distant metastasis. MolecularImaging.net (3/23) LinkedInFacebookTwitterEmail this Story
  • Other News
  Obstetrics Focus 
 
  • Higher postpartum glucose impairment risk seen in PCOS patients
    Data on 126 women with gestational diabetes found those with polycystic ovary syndrome were more than three times as likely to suffer from persistent glucose metabolism impairment compared with those who did not have PCOS. Shorter breast-feeding duration may play a role in higher postpartum glucose metabolism impairment in women with PCOS, researchers said. The findings were published in Diabetes Care. Medscape (free registration)/Reuters (3/22) LinkedInFacebookTwitterEmail this Story
  • SSRIs may increase risk of preeclampsia, study finds
    Canadian researchers who analyzed data from the Quebec Pregnancy Registry found that women who took selective serotonin reuptake inhibitors during their pregnancy were 60% more likely to develop preeclampsia. Researchers, however, advised women not to stop taking SSRIs without consulting their health care providers first. The study appeared in the British Journal of Clinical Pharmacology. HealthDay News (3/22) LinkedInFacebookTwitterEmail this Story
  • Prenatal PAH exposure may affect child behavior, study shows
    Children born to mothers exposed to higher levels of polycyclic aromatic hydrocarbons during pregnancy were more likely to experience anxiety, depression and attention problems by ages 6 and 7, a study in Environmental Health Perspectives found. However, researchers could not prove a cause-and-effect relationship between prenatal PAH exposure and childhood behavior problems. Yahoo!/HealthDay News (3/22) LinkedInFacebookTwitterEmail this Story
Georgetown University School of Nursing and Health Studies. Nursing@Georgetown is a Master of Science in Nursing program delivered online by Georgetown’s renowned School of Nursing and Health Studies. These programs are designed to help the next generation of nursing leaders achieve their career goals while improving the health and well-being of all people.
  AWHONN Spotlight on Research 
  • Study finds positive public attitudes about genetic testing for newborns
    A new Canadian study, published in the Journal of Obstetric, Gynecologic and Neonatal Nursing, supports the expansion of newborn screening (NBS) panels -- prompted by advances in genomic understanding and medical technology. The findings show public support for testing of disorders for which no treatments exist and also highlight parents' desire for informed consent before testing is undertaken. Of the 648 parents and nonparents surveyed, 69% believed that newborn genetic screening should be available for any condition as it could help parents with future reproductive decisions. More than half disagreed with the notion that newborn genetic testing should be available only for treatable health conditions, and 91% believed that parents should have access to their child's genetic information to allow them to prepare for any special needs for the child. Nearly all respondents believed that parental consent should be given before any genetic testing of a newborn is conducted. Read the abstract. LinkedInFacebookTwitterEmail this Story
  Neonatal Health 
  AWHONN News 
  • Worst-Case Scenario Webinar Series: Part I, Perinatal Code Management
    Introducing AWHONN's Worst-Case Scenario Webinar Series, a 3-part program to help nurses prevent bad outcomes and respond appropriately when things go wrong. Attend Part I of the series, Perinatal Code Management, on April 19 to learn how to identify clinical situations that can lead to cardiopulmonary arrest in a pregnant or newly delivered patient. You'll also learn how to use perinatal code drills/rehearsals and simulations to develop team activities to provide effective care during these emergencies. Register before Monday, April 9 and only pay $80 (a $79 savings) for the live webinar! One registration - all of your staff can attend. In addition to Perinatal Code Management on April 19, the Worst-Case Series also includes Demystifying DIC on 5/24 and Shoulder Dystocia: Improving Outcomes on 7/19. Register for the individual webinars or the entire series. Learn more and register. LinkedInFacebookTwitterEmail this Story
  • Obstetric Hemorrhage: A new resource from AWHONN
    Obstetric hemorrhage can be terrifying for patients and health care providers. Purchase AWHONN's new practice monograph Obstetric Hemorrhage for tools nurses need to plan and work with all health care providers involved in OB hemorrhage cases. Includes sample screening tools and physician orders as well as guidelines, self-assessments, clinical case studies and management templates. Addresses risk factors for OB hemorrhage and gives guidance on administering uterotonic agents for uterine atony, use of uterine tamponade balloon catheters to control bleeding, and objective estimation of blood loss. Try before you buy with our extensive online product preview. Obstetric Hemorrhage is a downloadable resource so you can start using it in your practice immediately after purchase. LinkedInFacebookTwitterEmail this Story
Learn more about AWHONN ->Join AWHONN/Renew Membership  |  Member Center  |  Journals & Research  |  AWHONN Store  |  Events & Webinars  |  Contact Us

  SmartQuote 
There is a time for work. And there is time for love. That leaves no other time."
--Coco Chanel,
French fashion designer


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Account Director:  Samuel Fuchs 202-470-1159
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
Follow AWHONN Online


 
 
 Recent AWHONN SmartBrief Issues:   Lead Editor:  Tom Parks
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2012 SmartBrief, Inc.® Legal Information